Deep learning can mine clinically useful information from histology. In gastrointestinal and liver cancer, such algorithms can predict survival and molecular alterations. Once pathology workflows are widely digitized, these methods could be used as inexpensive biomarkers. However, clinical translation requires training interdisciplinary researchers in both programming and clinical applications.
This is a preview of subscription content, log in via an institution to check access.
References
Kather, J. N. et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat. Med. 25, 1054–1056 (2019).
Griffin, J. & Treanor, D. Digital pathology in clinical use: where are we now and what is holding us back? Histopathology 70, 134–145 (2017).
Kather, J. N. et al. Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study. PLoS Med. 16, e1002730 (2019).
Coudray, N. et al. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning. Nat. Med. 24, 1559–1567 (2018).
Saillard, C. et al. Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides. Hepatology https://doi.org/10.1002/hep.31207 (2020).
Echle, A. et al. Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning. Gastroenterology https://doi.org/10.1053/j.gastro.2020.06.021 (2020).
Kather, J. N. et al. Pan-cancer image-based detection of clinically actionable genetic alterations. Nat. Cancer https://doi.org/10.1038/s43018-020-0087-6 (2020).
Fu, Y. et al. Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis. Preprint at bioRxiv https://doi.org/10.1101/813543 (2019).
Campanella, G. et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 25, 1301–1309 (2019).
Postelnicu, L. UK invests $65M to set up five new AI digital pathology and imaging centers. MobiHealthNews https://www.mobihealthnews.com/content/uk-invests-65m-set-five-new-ai-digital-pathology-and-imaging-centers (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.N.K. has an informal, unpaid advisory role at Pathomix (Heidelberg, Germany). J.C. receives consulting fees from Owkin, Inc. (New York, NY, USA) and Crosscope (San Francisco, CA, USA).
Additional information
Related links
EQUATOR network: https://www.equator-network.org/
Rights and permissions
About this article
Cite this article
Kather, J.N., Calderaro, J. Development of AI-based pathology biomarkers in gastrointestinal and liver cancer. Nat Rev Gastroenterol Hepatol 17, 591–592 (2020). https://doi.org/10.1038/s41575-020-0343-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-020-0343-3
- Springer Nature Limited
This article is cited by
-
Deep learning supported discovery of biomarkers for clinical prognosis of liver cancer
Nature Machine Intelligence (2023)
-
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Nature Cancer (2022)
-
Interpretable tumor differentiation grade and microsatellite instability recognition in gastric cancer using deep learning
Laboratory Investigation (2022)
-
Weakly supervised end-to-end artificial intelligence in gastrointestinal endoscopy
Scientific Reports (2022)
-
Swarm learning for decentralized artificial intelligence in cancer histopathology
Nature Medicine (2022)